Rhumbline Advisers Infinity Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.49 - $1.2 $39,476 - $96,676	-80,564 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.85 - $2.4 $4,880 - $13,780	5,742 Added 7.67%	80,564 $92,000
Q4 2021 Feb 10, 2022	SELL	$1.86 - $3.36 $1,871 - $3,380	-1,006 Reduced 1.33%	74,822 $168,000
Q3 2021 Nov 12, 2021	BUY	$1.52 - $3.82 $6,519 - $16,383	4,289 Added 6.0%	75,828 $259,000
Q2 2021 Aug 05, 2021	BUY	$2.66 - $3.47 $190,293 - $248,240	71,539 New	71,539 $214,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.